Logo image of AXTI

AXT INC (AXTI) Stock Fundamental Analysis

NASDAQ:AXTI - Nasdaq - US00246W1036 - Common Stock - Currency: USD

1.58  -0.71 (-31%)

After market: 1.5993 +0.02 (+1.22%)

Fundamental Rating

2

Taking everything into account, AXTI scores 2 out of 10 in our fundamental rating. AXTI was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of AXTI have multiple concerns. AXTI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AXTI has reported negative net income.
In the past year AXTI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: AXTI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: AXTI reported negative operating cash flow in multiple years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

AXTI has a Return On Assets of -2.91%. This is in the lower half of the industry: AXTI underperforms 62.96% of its industry peers.
Looking at the Return On Equity, with a value of -5.15%, AXTI is doing worse than 62.96% of the companies in the same industry.
Industry RankSector Rank
ROA -2.91%
ROE -5.15%
ROIC N/A
ROA(3y)1.17%
ROA(5y)0.66%
ROE(3y)1.67%
ROE(5y)1.02%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5

1.3 Margins

AXTI has a worse Gross Margin (25.41%) than 72.22% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
AXTI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-13.43%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

3

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
AXTI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

AXTI has an Altman-Z score of 0.70. This is a bad value and indicates that AXTI is not financially healthy and even has some risk of bankruptcy.
AXTI has a Altman-Z score of 0.70. This is in the lower half of the industry: AXTI underperforms 72.22% of its industry peers.
AXTI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
AXTI has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.7
ROIC/WACCN/A
WACC10.52%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

AXTI has a Current Ratio of 2.13. This indicates that AXTI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AXTI (2.13) is worse than 74.07% of its industry peers.
AXTI has a Quick Ratio of 1.04. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
AXTI's Quick ratio of 1.04 is on the low side compared to the rest of the industry. AXTI is outperformed by 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.04
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

AXTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.19%, which is quite impressive.
EPS 1Y (TTM)44.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.91%

3.2 Future

Based on estimates for the next years, AXTI will show a very strong growth in Earnings Per Share. The EPS will grow by 96.72% on average per year.
AXTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.45% yearly.
EPS Next Y76.2%
EPS Next 2Y96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.84%
Revenue Next 2Y19.45%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AXTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as AXTI's earnings are expected to grow with 96.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.72%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXT INC

NASDAQ:AXTI (2/21/2025, 8:02:31 PM)

After market: 1.5993 +0.02 (+1.22%)

1.58

-0.71 (-31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners50.65%
Inst Owner Change-5.99%
Ins Owners1.88%
Ins Owner Change6.4%
Market Cap70.28M
Analysts83.64
Price Target5.3 (235.44%)
Short Float %1.4%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.44%
Min EPS beat(2)22.5%
Max EPS beat(2)32.39%
EPS beat(4)4
Avg EPS beat(4)32.97%
Min EPS beat(4)22.5%
Max EPS beat(4)39.84%
EPS beat(8)7
Avg EPS beat(8)25.81%
EPS beat(12)11
Avg EPS beat(12)27.4%
EPS beat(16)14
Avg EPS beat(16)31.27%
Revenue beat(2)1
Avg Revenue beat(2)-3.39%
Min Revenue beat(2)-10.79%
Max Revenue beat(2)4.02%
Revenue beat(4)3
Avg Revenue beat(4)2.59%
Min Revenue beat(4)-10.79%
Max Revenue beat(4)13.99%
Revenue beat(8)3
Avg Revenue beat(8)-2.3%
Revenue beat(12)4
Avg Revenue beat(12)-1.76%
Revenue beat(16)7
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)-5.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.56%
EPS NY rev (1m)0%
EPS NY rev (3m)16.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 0.35
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS2.13
BVpS4.51
TBVpS4.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -5.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.41%
FCFM N/A
ROA(3y)1.17%
ROA(5y)0.66%
ROE(3y)1.67%
ROE(5y)1.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-13.43%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.2%
Cap/Sales 5.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.04
Altman-Z 0.7
F-Score3
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)296.5%
Cap/Depr(5y)348.44%
Cap/Sales(3y)18.53%
Cap/Sales(5y)20.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y76.2%
EPS Next 2Y96.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.91%
Revenue Next Year12.84%
Revenue Next 2Y19.45%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-538.98%
OCF growth 3Y-16.62%
OCF growth 5Y1.11%